← All companies
AbCellera Biologics Inc.
ABCL - CIK 0001703057
Market cap$1.57 B
Rank#2295
SEC filings297
The table below shows AbCellera Biologics Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $128.51M | $156.32M | $133.32M | $386.54M | $476.14M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | $6.34M | - | - | - | - |
| Total current assets | $728.23M | $751.37M | $871.99M | $1.03B | $929.80M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.